Related Experiment Video

Updated: Aug 23, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K

Breaking the Glass Ceiling: Low eGFR in the Use of MRA Therapy

Kevin Damman1, Jeffrey Testani2

  • 1University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.

JACC. Heart Failure
|November 3, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
chronic kidney diseasefinerenoneheart failuretype 2 diabetes

More Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.0K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.6K

Related Experiment Videos

Last Updated: Aug 23, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.0K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.6K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

Articles linked to this work by shared authors, journal, and citation graph.

Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1-7), in Acute Heart Failure: Insights from the PUSH-AHF trial.

Journal of cardiac failure·2026

Contemporary decongestion strategies in acute heart failure: an individual patient data analysis of three randomized controlled trials.

European journal of heart failure·2026

Intrarenal Determinants of GFR Decline During Loop Diuretic Therapy.

Hypertension (Dallas, Tex. : 1979)·2026

Mechanistic Specificity of Capillary Leak Indices: Validation in Heart Failure as a Negative Control.

Critical care medicine·2026

Handheld infrared thermography for triage of LVAD driveline infection: A prospective pilot diagnostic accuracy study.

JHLT open·2026

Indication for durable mechanical circulatory support: an expert opinion review.

ESC heart failure·2026

Skeletal Muscle Dysfunction in Heart Failure: Mechanistic Insights and Therapeutic Implications.

JACC. Heart failure·2026

Frailty Patterns, Reversibility, and Outcomes With a Magnetically Levitated Left Ventricular Assist Device.

JACC. Heart failure·2026

Defining Clinically Meaningful Within-Patient Changes in Heart Failure: JACC: Heart Failure Position Statement.

JACC. Heart failure·2026

Residual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes: Look AHEAD Ancillary Study.

JACC. Heart failure·2026

Ex Vivo Perfusion Unmasks a Proteomic Signature of Primary Graft Dysfunction in Donor Hearts.

JACC. Heart failure·2026

Myocardial Histopathology-Based Heart Failure Phenotyping.

JACC. Heart failure·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us